The prospect for a therapeutic window for treatment of ischemic stroke encourages the noninvasive investigation of metabolic changes in acute ischemia. Recently, localized proton spectroscopy became available at 1.5 -T magnetic resonance systems. In this study we evaluated the usefulness of combined magnetic resonance imaging and spectroscopy on the diagnosis of acute and chronic infarctions.
M agnetic resonance imaging (MRI) has already
improved the early detection of cerebral ischemia. Magnetic resonance (MR) can also be used to observe tissue metabolism in vivo, 1 -2 and magnetic resonance spectroscopy (MRS) has been successfully used to investigate cerebral ischemia in animals. 3 - 6 Recently, MRS became available as a wholebody MR system for the examination of patients. 7 " 9 In this study we have used combined proton MRI and MRS to examine patients during the acute as well as the chronic stage of middle cerebral artery (MCA) infarction. The purpose was to evaluate the feasibility and usefulness of MRI/MRS in the diagnosis of stroke patients.
Subjects and Methods
Only patients with ischemic infarctions of the MCA territory were chosen for this study. A total of 18 patients underwent a standardized MRI/MRS protocol after informed consent was obtained. Heart rate, electrocardiographic (Sirecust, Siemens), and blood oxy-genation (TM 8604, NONIN) values were continuously monitored during the MRI/MRS examination.
We examined eight patients, five men and three women, 47-80 years of age (mean, 57 years), in the chronic stage after stroke (8 months to 6 years). Two patients had suffered complete MCA infarctions, and the others had lesions in the parietal cortex («=2) and the subcortical white matter (n=4).
Ten patients, five men and five women, 30-79 years of age (mean, 60.3 years), suffering from acute infarction were investigated. All of them showed onset of hemiparesis <8 hours before the MRI/MRS examination (range, 4-8 hours; mean, 5.8 hours) and underwent computed tomographic (CT) scan and duplex sonography of the extracranial vessels. X-ray angiography was performed in five patients. Serial MRI/MRS examinations (on days 1, 6, and 12 after stroke) were obtained for three patients.
Volunteers (nine women, seven men) were examined to optimize the MRI/MRS protocol. They were 21-63 years of age (mean, 41 years) and had no history or symptoms of previous neurological or cardiovascular diseases. Combined MRI/MRS investigations were carried out with a 1.5-T iron-shielded system (Magnetom, Siemens) equipped with a 10 mT/m gradient system and a standard circularly polarized head coil. The imaging protocol consisted of a sagittal Tl-weighted multislice spin-echo sequence (repetition time [TR] , 550 msec; echo time [TE] , 15 msec) and a multislice proton density (PD)/T2 -weighted double echo sequence (TR,
Ch
Cr/PCr Localized spectra were acquired with a previously described stimulated echo sequence. 10 Size and location of the volume of interest (VOI) were determined by the intersection of three slice-selective radio-frequency pulses. The water proton signal was suppressed by a preceding chemical shift-selective radio-frequency pulse. The patients were not moved between the time that the MRI and MRS examinations were done, and the VOIs were targeted from T2-weighted scans. With respect to the time constraints of a clinical examination, we used a 1,500-msec TR and 16-27-ml VOIs. The TE was 270 msec to rephase the doublet of lactate (lac) methyl protons (J, 7 Hz) together with the singlet resonances and to avoid contributions from short T2 compounds like fatty acids. Spectra were accumulated for 3-9 minutes (128-384 NEX). The total examination time for MRI and MRS was <60 minutes. The spectra were processed in the time domain by a 1-2-Hz linebroadening Gaussian function and displayed relative to water (chemical shift, 4.7 ppm). Figure 1 shows two typical spectra from volunteers. The resonances were assigned to choline (Ch) ([N-CH 3 ] 3 ) at 3.2 ppm, creatine/phosphocreatine (Cr/PCr) (N-CH 3 ) at 3 ppm, and the methyl group of JV-acetyl aspartate (NAA) at 2 ppm.
Results
1011 There were no significant interindividual differences (Table 1) .
Localized proton spectra from areas of infarctions were obtained for all patients. One patient who suffered from concomitant lower back pain did not tolerate the entire protocol. Thus, we limited the acquisition time for the localized spectrum to 3 minutes (128 NEX) and achieved diagnostic images together with interpretable spectra within 35 minutes (Figures 2A-2C ). The MRI/ MRS examination did not influence heart rate, electrocardiographic, or blood oxygenation parameters of the patients.
Chronic ischemic lesions showed decreased signals for NAA, Ch, and Cr/PCr. Metabolite levels maintained higher values if the MRI indicated preservation of astroglial architecture (n=6) rather than postischemic cysts (n=2) ( Figures 3A and 3B and Table 1) . MRI in 10 patients demonstrated acute ischemia, and the CT scan was negative for six of them. The lesions appeared signal intense on PD-and T2-weighted scans and were isointense or slightly hypointense to the surrounding gray and white matter on Tl-weighted images. The size and location of the lesions were correlated with the severity of motor deficit and aphasia.
Localized spectra of the lesions revealed increased lac levels and decreased NAA levels in all of the patients. The range of spectral changes was different in the patients (Table 1 ). The highest lac levels were found in complete infarctions of the MCA territory and in insular infarctions. iV-acetyl aspartate depletion was more pronounced if the entire MCA territory was involved. In a patient who was examined within 4 hours, MRI poorly denned the ischemia, but spectral changes were marked (Figures 4A-4C ). Spectral changes were less prominent in cortical and capsular infarctions. Decreasing signals for lac were monitored in a patient in whom partial recovery of hemiparesis was observed (Figures 2A-2C) . echo sequence accurately suppressed signals originating outside the VOI. Mobile fat was never present in our spectra even if the VOI was positioned close to the skull (Figure 2 ). Spectral resolutions of 4-6 Hz were achieved within <10 minutes of the local magnetic field optimization. The examination time for MRI/MRS could be minimized to 30 minutes in a patient with lower back pain. In concordance with previous studies, spectra from the volunteers did not show significant interindividual differences. 11 In our spectra, signals of physiological lac concentrations were not detected because of the limitations of the signal-to-noise ratio within the time constraints of a clinical examination.
Discussion
Despite the fact that all of the patients had comparable neurological symptoms, MRI revealed considerable variations in the location and distribution of ischemic lesions. T2-weighted images were most sensitive to acute ischemia and showed signal-intense lesions in all patients. This proved to be necessary for positioning and interpretation of localized MRS.
Although a definite role for the MRS-detectable NAA pool remains to be elucidated, decreased NAA levels have been found in brain tumors and infarctions. Our results in acute and chronic infarctions support the view that NAA is associated with the presence of viable neurons. 9 Also positron emission tomographic studies that have demonstrated a decreased 18 F-deoxyglucose use in chronic infarction 12 have also indicated the loss of metabolically active neurons.
31
P-MR spectra of chronic infarctions have demonstrated a general diminution of phosphate compounds but have otherwise appeared normal. 7 This suggests tissue loss and normal energy metabolism of the surviv-ing cells, a finding that is consistent with the absence of lac in our proton spectra of chronic infarctions.
In the acute stage of cerebral infarction, MRS yielded elevations of lac and decreases of NAA levels in all patients. The range of spectral changes varied considerably within the different patients. Partial-volume averaging of normal and ischemic tissue explains these variations in patients with small capsular and parietal infarctions according to the size of the VOI. However, different levels of lac and NAA were also found in spectra of extensive infarctions (Figures 4A-4C) . These results indicate that infarctions with a comparable appearance on MR scans were composed of cells in different metabolic states. Lactate may result from anaerobic glycolysis, as has been demonstrated by combined 31 P-and proton MRS investigations of experimentally induced cerebral ischemia, 6 but is also agonally produced by irreversibly damaged cells. In our protocol, differentiation of the metabolically active lac pool was not possible, but it may be achieved with 13 Cglucose labeling in the future. 13 Because lac is eliminated from the brain by diffusion, increased levels of lac in two serial studies ( Figure 4C ) support the notion that the VOI included metabolically active cells. In another patient, sequential investigations showed decreased lac levels ( Figure 2C ), indicating that repeated examinations offer direct insight into the metabolic activity of surviving cells in cerebral infarction.
In this study we did not observe lac in chronic infarctions 8 months to several years after stroke, so the presence of lac contributes to the distinction between acute and chronic ischemic lesions. This is not contradictory to previous reports showing elevated lac levels in the time range of 8 days after transient ischemic attack 14 and as long as 3 months after stroke. 8 Magnetic resonance spectroscopy in these lesions was more sensitive than MRI and reflected ongoing metabolic alterations.
In vivo MRS presently does not provide quantification of metabolites because no external standard can be added to the examined tissue. Calculation of relaxation times in volunteers 11 is helpful in estimating saturation effects, but they may not exactly predict Tl and T2 relaxation changes in ischemic tissue if edema and microhemorrhage are present. Using assumptions that have recently been applied to a patient examined with proton MRS, 9 we found that lac concentrations ranged from 2 mmol to 30 mmol in our patients.
In conclusion, we have demonstrated an MRI/MRS protocol that can be used by physicians and is tolerable to patients. The combination of MRS and T2-weighted imaging is mandatory for accurate localization and interpretation of the spectra. We have shown that in vivo observation of Ch, Cr/PCr, NAA, and lac offers metabolic information for the differentiation between acute and chronic infarction as well as the normal brain.
